Presseaussendungen zu "Balance-Sheet"

2.907 Aussendungen
vorige Seite Seite 1 von 194 nächste Seite

BMO Financial Group Reports Fourth Quarter and Fiscal 2019 Results

- For the fourth quarter ended October 31, 2019, BMO Financial Group (TSX:BMO) (NYSE:BMO) recorded net income of $1,194 million or $1.78 per share on a reported basis, and net income of $1,607 million or …

OTE0002
03.12.2019 13:14

EANS-News: Schoeller-Bleckmann Oilfield Equipment AG / Sound International Business Development in Q1-3 2019

Sales rise to MEUR 346 in the First Three Quarters of 2019, EBIT stable at MEUR 55

EANS-News: Fonderie Mario Mazzucconi SpA / Communications pursuant to Article 12(viii)(b) of the Terms and Conditions of the «Fonderie Mario Mazzucconi SpA - Tasso Fisso 6,5% - 2018/2023» bond-ISIN:IT0005320756

Communications pursuant to Article 12(viii)(b) of the Terms and Conditions of the «Fonderie Mario Mazzucconi SpA - Tasso Fisso 6,5% - 2018/2023» bond-ISIN:IT0005320756

OTE0004
15.11.2019 18:56

EANS-News: Fonderie Mario Mazzucconi S.p.A. /

Fonderie Mario Mazzucconi SpA / Communications pursuant to Article 12(viii)(b) of the Terms and Conditions of the «Fonderie Mario Mazzucconi SpA - Tasso Fisso 6,5% - 2018/2023» bond-ISIN:IT0005320756

OTE0003
15.11.2019 18:48

EANS-News: Lenzing AG / Lenzing solid in a very difficult market environment

Financial Figures/Balance Sheet/Quarterly Report/Company Information

OTE0002
06.11.2019 07:28

EANS-Adhoc: Austrian Post / MILESTONES AND OUTLOOK FOR 2019 AND 2020

Quarterly Report/Company Information 29.10.2019

OTE0003
29.10.2019 11:34

Infosys: Double Digit Growth for the Fourth Consecutive Quarter, Coupled With 1.2% Operating Margin Expansion in Q2

"Our performance was robust on multiple dimensions - revenue growth, digital growth, operating margins, operational efficiencies, large deal signings and reduction in attrition," said Salil Parekh, CEO and …

OTE0003
11.10.2019 16:22

UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases

- Will enhance UCB's leadership potential in myasthenia gravis by adding zilucoplan, a peptide inhibitor of complement component 5 (C5) currently in phase 3, to the UCB pipeline alongside to UCB's …

OTE0003
10.10.2019 09:38

EANS-News: AGRANA reaffirms significant earnings growth for full 2019|20 financial year

EBIT in first half still significantly below year-earlier period – Positive full-year forecast remains in place

OTE0002
10.10.2019 07:30

RERC präsentiert Briefing zum europäischen Immobilienmarkt. Thema des Berichts: "Risiken einplanen".

RERC, ein Unternehmen von SitusAMC, hat heute sein European Real Estate Market Briefing (Briefing zum europäischen Immobilienmarkt) präsentiert.

OTS0128
03.10.2019 12:28
vorige Seite nächste Seite